As we move further and further into an age of massive information sharing, it is logical that "sponsored research" remains a focal point in litigation over alleged or actual physical injuries and disease processes that evolve over time. More specifically, the pressures are growing as to medical advisors and disclosures involved in researching and communicating

Good science depends on access to full data. A new study from the University of California at San Francisco highlights the point. In this instance, scientists wondered about the accuracy of peer-reviewed papers purporting to show relatively modest carcinogenic effects from tobacco additives. The earlier paper resulted from a study the tobacco industry called Project


This August 29, 2011 Financial Times article by Andrew Jack  provides an update on big pharma, litigation, disclosures and graphics on disclosed payments to doctors.


Kudos to two Duane Morris defense lawyers for this  pragmatic, new  National Law Journal article about industry sponsored research. The entire article should be read.  Hopefully you can

As trust breaks down, demands increase for disclosure. Accordingly, fascinating things are happening in the US as Dodd-Frank act regulators involved with financial institutions are required to disclose meetings with constituents, such as the regulated entities and "public interest groups."  The Conglomerate blog includes this informative post to provide a primer – and much more

Must economists and law professors disclose financial interests and conflicts of interest when they write ? Common sense says:  of course they must disclose.

History, however, shows that myriad economists and some Wall Street denizens fail to recognize or disclose conflicts of interest. An especially biting view is laid out in this wonderful post

Medical research often is  "sponsored by industry," for obvious reasons. And, in general, more research is good. There are, however,  said to be "controversies " about whether all medical study information should be required to be publicly published. The topic occasionally  has been covered on this blog under the category of "sponsored research," which is available on the right

Sponsored research is a short-hand term for situations in which researchers also receive payments from pharma or other entities.  Lots of positions are taken on the topic, and the area is fraught with arguments about what is "good,"  "right,"  and "practical."

The topic has new grist for argument now that ScienceDaily for March 20 brings news of a study

A hat tip to David Zaring at The Conglomerate for this post that covers some interesting ground regarding “risk” issue, including regulatory issues and issues regarding product liability and other tort claims. One part of the post also covers a new book on the safety – or lack of safety – of imports into